<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://physrev.physiology.org">
<title>Physiological Reviews recent issues</title>
<link>http://physrev.physiology.org</link>
<description>Physiological Reviews RSS feed -- recent issues</description>
<prism:eIssn>1522-1210</prism:eIssn>
<prism:publicationName>Physiological Reviews</prism:publicationName>
<prism:issn>0031-9333</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/841?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/887?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/919?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/983?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/1009?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/1089?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/1119?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/3/1183?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/333?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/351?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/389?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/421?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/451?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/489?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/515?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/557?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/581?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/611?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/639?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/673?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/729?rss=1" />
  <rdf:li rdf:resource="http://physrev.physiology.org/cgi/content/abstract/88/2/769?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://physrev.physiology.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://physrev.physiology.org/icons/banner/title.gif">
<title>Physiological Reviews</title>
<url>http://physrev.physiology.org/icons/banner/title.gif</url>
<link>http://physrev.physiology.org</link>
</image>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/841?rss=1">
<title><![CDATA[Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/841?rss=1</link>
<description><![CDATA[ 
<P>The membrane proteins CD38 and CD157 belong to an evolutionarily conserved family of enzymes that play crucial roles in human physiology. Expressed in distinct patterns in most tissues, CD38 (and CD157) cleaves NAD<SUP>+</SUP> and NADP<SUP>+</SUP>, generating cyclic ADP ribose (cADPR), NAADP, and ADPR. These reaction products are essential for the regulation of intracellular Ca<SUP>2+</SUP>, the most ancient and universal cell signaling system. The entire family of enzymes controls complex processes, including egg fertilization, cell activation and proliferation, muscle contraction, hormone secretion, and immune responses. Over the course of evolution, the molecules have developed the ability to interact laterally and frontally with other surface proteins and have acquired receptor-like features. As detailed in this review, the loss of CD38 function is associated with impaired immune responses, metabolic disturbances, and behavioral modifications in mice. CD38 is a powerful disease marker for human leukemias and myelomas, is directly involved in the pathogenesis and outcome of human immunodeficiency virus infection and chronic lymphocytic leukemia, and controls insulin release and the development of diabetes. Here, the data concerning diseases are examined in view of potential clinical applications in diagnosis, prognosis, and therapy. The concluding remarks try to frame all of the currently available information within a unified working model that takes into account both the enzymatic and receptorial functions of the molecules.</P>
]]></description>
<dc:creator><![CDATA[Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., Aydin, S.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00035.2007</dc:identifier>
<dc:title><![CDATA[Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>886</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>841</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/887?rss=1">
<title><![CDATA[LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/887?rss=1</link>
<description><![CDATA[ 
<P>The LDL receptor-related protein (originally called LRP, but now referred to as LRP1) is a large endocytic receptor that is widely expressed in several tissues. LRP1 is a member of the LDL receptor family that plays diverse roles in various biological processes including lipoprotein metabolism, degradation of proteases, activation of lysosomal enzymes, and cellular entry of bacterial toxins and viruses. Deletion of the LRP1 gene leads to lethality in mice, revealing a critical, but as of yet, undefined role in development. Tissue-specific gene deletion studies reveal an important contribution of LRP1 in the vasculature, central nervous system, macrophages, and adipocytes. Three important properties of LRP1 dictate its diverse role in physiology: <I>1</I>) its ability to recognize more than 30 distinct ligands, <I>2</I>) its ability to bind a large number of cytoplasmic adaptor proteins via determinants located on its cytoplasmic domain in a phosphorylation-specific manner, and <I>3</I>) its ability to associate with and modulate the activity of other transmembrane receptors such as integrins and receptor tyrosine kinases.</P>
]]></description>
<dc:creator><![CDATA[Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., Strickland, D. K.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00033.2007</dc:identifier>
<dc:title><![CDATA[LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>918</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>887</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/919?rss=1">
<title><![CDATA[Genesis and Regulation of the Heart Automaticity]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/919?rss=1</link>
<description><![CDATA[ 
<P>The heart automaticity is a fundamental physiological function in higher organisms. The spontaneous activity is initiated by specialized populations of cardiac cells generating periodical electrical oscillations. The exact cascade of steps initiating the pacemaker cycle in automatic cells has not yet been entirely elucidated. Nevertheless, ion channels and intracellular Ca<SUP>2+</SUP> signaling are necessary for the proper setting of the pacemaker mechanism. Here, we review the current knowledge on the cellular mechanisms underlying the generation and regulation of cardiac automaticity. We discuss evidence on the functional role of different families of ion channels in cardiac pacemaking and review recent results obtained on genetically engineered mouse strains displaying dysfunction in heart automaticity. Beside ion channels, intracellular Ca<SUP>2+</SUP> release has been indicated as an important mechanism for promoting automaticity at rest as well as for acceleration of the heart rate under sympathetic nerve input. The potential links between the activity of ion channels and Ca<SUP>2+</SUP> release will be discussed with the aim to propose an integrated framework of the mechanism of automaticity.</P>
]]></description>
<dc:creator><![CDATA[Mangoni, M. E., Nargeot, J.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00018.2007</dc:identifier>
<dc:title><![CDATA[Genesis and Regulation of the Heart Automaticity]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>982</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>919</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/983?rss=1">
<title><![CDATA[Activity-Dependent Structural and Functional Plasticity of Astrocyte-Neuron Interactions]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/983?rss=1</link>
<description><![CDATA[ 
<P>Observations from different brain areas have established that the adult nervous system can undergo significant experience-related structural changes throughout life. Less familiar is the notion that morphological plasticity affects not only neurons but glial cells as well. Yet there is abundant evidence showing that astrocytes, the most numerous cells in the mammalian brain, are highly mobile. Under physiological conditions as different as reproduction, sensory stimulation, and learning, they display a remarkable structural plasticity, particularly conspicuous at the level of their lamellate distal processes that normally ensheath all portions of neurons. Distal astrocytic processes can undergo morphological changes in a matter of minutes, a remodeling that modifies the geometry and diffusion properties of the extracellular space and relationships with adjacent neuronal elements, especially synapses. Astrocytes respond to neuronal activity via ion channels, neurotransmitter receptors, and transporters on their processes; they transmit information via release of neuroactive substances. Where astrocytic processes are mobile then, astrocytic-neuronal interactions become highly dynamic, a plasticity that has important functional consequences since it modifies extracellular ionic homeostasis, neurotransmission, gliotransmission, and ultimately neuronal function at the cellular and system levels. Although a complete picture of intervening cellular mechanisms is lacking, some have been identified, notably certain permissive molecular factors common to systems capable of remodeling (cell surface and extracellular matrix adhesion molecules, cytoskeletal proteins) and molecules that appear specific to each system (neuropeptides, neurotransmitters, steroids, growth factors) that trigger or reverse the morphological changes.</P>
]]></description>
<dc:creator><![CDATA[Theodosis, D. T., Poulain, D. A., Oliet, S. H. R.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00036.2007</dc:identifier>
<dc:title><![CDATA[Activity-Dependent Structural and Functional Plasticity of Astrocyte-Neuron Interactions]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>1008</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>983</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/1009?rss=1">
<title><![CDATA[Regulation of Coronary Blood Flow During Exercise]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/1009?rss=1</link>
<description><![CDATA[ 
<P>Exercise is the most important physiological stimulus for increased myocardial oxygen demand. The requirement of exercising muscle for increased blood flow necessitates an increase in cardiac output that results in increases in the three main determinants of myocardial oxygen demand: heart rate, myocardial contractility, and ventricular work. The approximately sixfold increase in oxygen demands of the left ventricle during heavy exercise is met principally by augmenting coronary blood flow (~5-fold), as hemoglobin concentration and oxygen extraction (which is already 70&ndash;80% at rest) increase only modestly in most species. In contrast, in the right ventricle, oxygen extraction is lower at rest and increases substantially during exercise, similar to skeletal muscle, suggesting fundamental differences in blood flow regulation between these two cardiac chambers. The increase in heart rate also increases the relative time spent in systole, thereby increasing the net extravascular compressive forces acting on the microvasculature within the wall of the left ventricle, in particular in its subendocardial layers. Hence, appropriate adjustment of coronary vascular resistance is critical for the cardiac response to exercise. Coronary resistance vessel tone results from the culmination of myriad vasodilator and vasoconstrictors influences, including neurohormones and endothelial and myocardial factors. Unraveling of the integrative mechanisms controlling coronary vasodilation in response to exercise has been difficult, in part due to the redundancies in coronary vasomotor control and differences between animal species. Exercise training is associated with adaptations in the coronary microvasculature including increased arteriolar densities and/or diameters, which provide a morphometric basis for the observed increase in peak coronary blood flow rates in exercise-trained animals. In larger animals trained by treadmill exercise, the formation of new capillaries maintains capillary density at a level commensurate with the degree of exercise-induced physiological myocardial hypertrophy. Nevertheless, training alters the distribution of coronary vascular resistance so that more capillaries are recruited, resulting in an increase in the permeability-surface area product without a change in capillary numerical density. Maintenance of - and &szlig;-adrenergic tone in the presence of lower circulating catecholamine levels appears to be due to increased receptor responsiveness to adrenergic stimulation. Exercise training also alters local control of coronary resistance vessels. Thus arterioles exhibit increased myogenic tone, likely due to a calcium-dependent protein kinase C signaling-mediated alteration in voltage-gated calcium channel activity in response to stretch. Conversely, training augments endothelium-dependent vasodilation throughout the coronary microcirculation. This enhanced responsiveness appears to result principally from an increased expression of nitric oxide (NO) synthase. Finally, physical conditioning decreases extravascular compressive forces at rest and at comparable levels of exercise, mainly because of a decrease in heart rate. Impedance to coronary inflow due to an epicardial coronary artery stenosis results in marked redistribution of myocardial blood flow during exercise away from the subendocardium towards the subepicardium. However, in contrast to the traditional view that myocardial ischemia causes maximal microvascular dilation, more recent studies have shown that the coronary microvessels retain some degree of vasodilator reserve during exercise-induced ischemia and remain responsive to vasoconstrictor stimuli. These observations have required reassessment of the principal sites of resistance to blood flow in the microcirculation. A significant fraction of resistance is located in small arteries that are outside the metabolic control of the myocardium but are sensitive to shear and nitrovasodilators. The coronary collateral system embodies a dynamic network of interarterial vessels that can undergo both long- and short-term adjustments that can modulate blood flow to the dependent myocardium. Long-term adjustments including recruitment and growth of collateral vessels in response to arterial occlusion are time dependent and determine the maximum blood flow rates available to the collateral-dependent vascular bed during exercise. Rapid short-term adjustments result from active vasomotor activity of the collateral vessels. Mature coronary collateral vessels are responsive to vasodilators such as nitroglycerin and atrial natriuretic peptide, and to vasoconstrictors such as vasopressin, angiotensin II, and the platelet products serotonin and thromboxane A<SUB>2</SUB>. During exercise, &szlig;-adrenergic activity and endothelium-derived NO and prostanoids exert vasodilator influences on coronary collateral vessels. Importantly, alterations in collateral vasomotor tone, e.g., by exogenous vasopressin, inhibition of endogenous NO or prostanoid production, or increasing local adenosine production can modify collateral conductance, thereby influencing the blood supply to the dependent myocardium. In addition, vasomotor activity in the resistance vessels of the collateral perfused vascular bed can influence the volume and distribution of blood flow within the collateral zone. Finally, there is evidence that vasomotor control of resistance vessels in the normally perfused regions of collateralized hearts is altered, indicating that the vascular adaptations in hearts with a flow-limiting coronary obstruction occur at a global as well as a regional level. Exercise training does not stimulate growth of coronary collateral vessels in the normal heart. However, if exercise produces ischemia, which would be absent or minimal under resting conditions, there is evidence that collateral growth can be enhanced. In addition to ischemia, the pressure gradient between vascular beds, which is a determinant of the flow rate and therefore the shear stress on the collateral vessel endothelium, may also be important in stimulating growth of collateral vessels.</P>
]]></description>
<dc:creator><![CDATA[Duncker, D. J., Bache, R. J.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00045.2006</dc:identifier>
<dc:title><![CDATA[Regulation of Coronary Blood Flow During Exercise]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>1086</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1009</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/1089?rss=1">
<title><![CDATA[Intracellular Transport and Kinesin Superfamily Proteins, KIFs: Structure, Function, and Dynamics]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/1089?rss=1</link>
<description><![CDATA[ 
<P>Various molecular cell biology and molecular genetic approaches have indicated significant roles for kinesin superfamily proteins (KIFs) in intracellular transport and have shown that they are critical for cellular morphogenesis, functioning, and survival. KIFs not only transport various membrane organelles, protein complexes, and mRNAs for the maintenance of basic cellular activity, but also play significant roles for various mechanisms fundamental for life, such as brain wiring, higher brain functions such as memory and learning and activity-dependent neuronal survival during brain development, and for the determination of important developmental processes such as left-right asymmetry formation and suppression of tumorigenesis. Accumulating data have revealed a molecular mechanism of cargo recognition involving scaffolding or adaptor protein complexes. Intramolecular folding and phosphorylation also regulate the binding activity of motor proteins. New techniques using molecular biophysics, cryoelectron microscopy, and X-ray crystallography have detected structural changes in motor proteins, synchronized with ATP hydrolysis cycles, leading to the development of independent models of monomer and dimer motors for processive movement along microtubules.</P>
]]></description>
<dc:creator><![CDATA[Hirokawa, N., Noda, Y.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00023.2007</dc:identifier>
<dc:title><![CDATA[Intracellular Transport and Kinesin Superfamily Proteins, KIFs: Structure, Function, and Dynamics]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>1118</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1089</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/1119?rss=1">
<title><![CDATA[Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/1119?rss=1</link>
<description><![CDATA[ 
<P>Epithelial cells of the gastrointestinal tract are an important barrier between the "milieu interne" and the luminal content of the gut. They perform transport of nutrients, salts, and water, which is essential for the maintenance of body homeostasis. In these epithelia, a variety of K<SUP>+</SUP> channels are expressed, allowing adaptation to different needs. This review provides an overview of the current literature that has led to a better understanding of the multifaceted function of gastrointestinal K<SUP>+</SUP> channels, thereby shedding light on pathophysiological implications of impaired channel function. For instance, in gastric mucosa, K<SUP>+</SUP> channel function is a prerequisite for acid secretion of parietal cells. In epithelial cells of small intestine, K<SUP>+</SUP> channels provide the driving force for electrogenic transport processes across the plasma membrane, and they are involved in cell volume regulation. Fine tuning of salt and water transport and of K<SUP>+</SUP> homeostasis occurs in colonic epithelia cells, where K<SUP>+</SUP> channels are involved in secretory and reabsorptive processes. Furthermore, there is growing evidence for changes in epithelial K<SUP>+</SUP> channel expression during cell proliferation, differentiation, apoptosis, and, under pathological conditions, carcinogenesis. In the future, integrative approaches using functional and postgenomic/proteomic techniques will help us to gain comprehensive insights into the role of K<SUP>+</SUP> channels of the gastrointestinal tract.</P>
]]></description>
<dc:creator><![CDATA[Heitzmann, D., Warth, R.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00020.2007</dc:identifier>
<dc:title><![CDATA[Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>1182</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1119</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/3/1183?rss=1">
<title><![CDATA[Histamine in the Nervous System]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/3/1183?rss=1</link>
<description><![CDATA[ 
<P>Histamine is a transmitter in the nervous system and a signaling molecule in the gut, the skin, and the immune system. Histaminergic neurons in mammalian brain are located exclusively in the tuberomamillary nucleus of the posterior hypothalamus and send their axons all over the central nervous system. Active solely during waking, they maintain wakefulness and attention. Three of the four known histamine receptors and binding to glutamate NMDA receptors serve multiple functions in the brain, particularly control of excitability and plasticity. H1 and H2 receptor-mediated actions are mostly excitatory; H3 receptors act as inhibitory auto- and heteroreceptors. Mutual interactions with other transmitter systems form a network that links basic homeostatic and higher brain functions, including sleep-wake regulation, circadian and feeding rhythms, immunity, learning, and memory in health and disease.</P>
]]></description>
<dc:creator><![CDATA[Haas, H. L., Sergeeva, O. A., Selbach, O.]]></dc:creator>
<dc:date>2008-07-14</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00043.2007</dc:identifier>
<dc:title><![CDATA[Histamine in the Nervous System]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>1241</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1183</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/333?rss=1">
<title><![CDATA[Nonsynaptic Chemical Transmission Through Nicotinic Acetylcholine Receptors]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/333?rss=1</link>
<description><![CDATA[ 
<P>This review attempts to organize the different aspects of nicotinic transmission in the context of nonsynaptic interactions. Nicotinic acetylcholine receptors (nAChRs) dominantly operate in the nonsynaptic mode in the central nervous system despite their ligand-gated ion-channel nature, which would otherwise be better suited for fast synaptic transmission. This fast form of nonsynaptic transmission, most likely unique to nAChRs, represents a new avenue in the communication platforms of the brain. Cholinergic messages received by nAChRs, arriving at a later phase following synaptic activation, can interfere with dendritic signal integration. Nicotinic transmission plays a role in both neural plasticity and cellular learning processes, as well as in long-term changes in basic activity through fast activation, desensitization of receptors, and fluctuations of the steady-state levels of ACh. ACh release can contribute to plastic changes via activation of nAChRs in neurons and therefore plays a role in learning and memory in different brain regions. Assuming that nAChRs in human subjects are ready to receive long-lasting messages from the extracellular space because of their predominantly nonsynaptic distribution, they offer an ideal target for drug therapy at low, nontoxic drug levels.</P>
]]></description>
<dc:creator><![CDATA[Lendvai, B., Vizi, E. S.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00040.2006</dc:identifier>
<dc:title><![CDATA[Nonsynaptic Chemical Transmission Through Nicotinic Acetylcholine Receptors]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>349</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>333</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/351?rss=1">
<title><![CDATA[CLC-0 and CFTR: Chloride Channels Evolved From Transporters]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/351?rss=1</link>
<description><![CDATA[ 
<P>CLC-0 and cystic fibrosis transmembrane conductance regulator (CFTR) Cl<SUP>&ndash;</SUP> channels play important roles in Cl<SUP>&ndash;</SUP> transport across cell membranes. These two proteins belong to, respectively, the CLC and ABC transport protein families whose members encompass both ion channels and transporters. Defective function of members in these two protein families causes various hereditary human diseases. Ion channels and transporters were traditionally viewed as distinct entities in membrane transport physiology, but recent discoveries have blurred the line between these two classes of membrane transport proteins. CLC-0 and CFTR can be considered operationally as ligand-gated channels, though binding of the activating ligands appears to be coupled to an irreversible gating cycle driven by an input of free energy. High-resolution crystallographic structures of bacterial CLC proteins and ABC transporters have led us to a better understanding of the gating properties for CLC and CFTR Cl<SUP>&ndash;</SUP> channels. Furthermore, the joined force between structural and functional studies of these two protein families has offered a unique opportunity to peek into the evolutionary link between ion channels and transporters. A promising byproduct of this exercise is a deeper mechanistic insight into how different transport proteins work at a fundamental level.</P>
]]></description>
<dc:creator><![CDATA[Chen, T.-Y., Hwang, T.-C.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00058.2006</dc:identifier>
<dc:title><![CDATA[CLC-0 and CFTR: Chloride Channels Evolved From Transporters]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>387</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>351</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/389?rss=1">
<title><![CDATA[Cardiac Remodeling in Obesity]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/389?rss=1</link>
<description><![CDATA[ 
<P>The dramatic increase in the prevalence of obesity and its strong association with cardiovascular disease have resulted in unprecedented interest in understanding the effects of obesity on the cardiovascular system. A consistent, but puzzling clinical observation is that obesity confers an increased susceptibility to the development of cardiac disease, while at the same time affording protection against subsequent mortality (termed the obesity paradox). In this review we focus on evidence available from human and animal model studies and summarize the ways in which obesity can influence structure and function of the heart. We also review current hypotheses regarding mechanisms linking obesity and various aspects of cardiac remodeling. There is currently great interest in the role of adipokines, factors secreted from adipose tissue, and their role in the numerous cardiovascular complications of obesity. Here we focus on the role of leptin and the emerging promise of adiponectin as a cardioprotective agent. The challenge of understanding the association between obesity and heart failure is complicated by the multifaceted interplay between various hemodynamic, metabolic, and other physiological factors that ultimately impact the myocardium. Furthermore, the end result of obesity-associated changes in the myocardial structure and function may vary at distinct stages in the progression of remodeling, may depend on the individual pathophysiology of heart failure, and may even remain undetected for decades before clinical manifestation. Here we summarize our current knowledge of this complex yet intriguing topic.</P>
]]></description>
<dc:creator><![CDATA[Abel, E. D., Litwin, S. E., Sweeney, G.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00017.2007</dc:identifier>
<dc:title><![CDATA[Cardiac Remodeling in Obesity]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>419</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>389</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/421?rss=1">
<title><![CDATA[Ca2+-Operated Transcriptional Networks: Molecular Mechanisms and In Vivo Models]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/421?rss=1</link>
<description><![CDATA[ 
<P>Calcium is the most universal signal used by living organisms to convey information to many different cellular processes. In this review we present well-known and recently identified proteins that sense and decode the calcium signal and are key elements in the nucleus to regulate the activity of various transcriptional networks. When possible, the review also presents in vivo models in which the genes encoding these calcium sensors-transducers have been modified, to emphasize the critical role of these Ca<SUP>2+</SUP>-operated mechanisms in many physiological functions.</P>
]]></description>
<dc:creator><![CDATA[Mellstrom, B., Savignac, M., Gomez-Villafuertes, R., Naranjo, J. R.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00041.2005</dc:identifier>
<dc:title><![CDATA[Ca2+-Operated Transcriptional Networks: Molecular Mechanisms and In Vivo Models]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>449</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>421</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/451?rss=1">
<title><![CDATA[Properties of the Glomerular Barrier and Mechanisms of Proteinuria]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/451?rss=1</link>
<description><![CDATA[ 
<P>This review focuses on the intricate properties of the glomerular barrier. Other reviews have focused on podocyte biology, mesangial cells, and the glomerular basement membrane (GBM). However, since all components of the glomerular membrane are important for its function, proteinuria will occur regardless of which layer is affected by disease. We review the properties of endothelial cells and their surface layer, the GBM, and podocytes, discuss various methods of studying glomerular permeability, and analyze data concerning the restriction of solutes by size, charge, and shape. We also review the physical principles of transport across biological or artificial membranes and various theoretical models used to predict the fluxes of solutes and water. The glomerular barrier is highly size and charge selective, in qualitative agreement with the classical studies performed 30 years ago. The small amounts of albumin filtered will be reabsorbed by the megalin-cubulin complex and degraded by the proximal tubular cells. At present, there is no unequivocal evidence for reuptake of intact albumin from urine. The cellular components are the key players in restricting solute transport, while the GBM is responsible for most of the resistance to water flow across the glomerular barrier.</P>
]]></description>
<dc:creator><![CDATA[Haraldsson, B., Nystrom, J., Deen, W. M.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00055.2006</dc:identifier>
<dc:title><![CDATA[Properties of the Glomerular Barrier and Mechanisms of Proteinuria]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>487</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>451</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/489?rss=1">
<title><![CDATA[Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell Migration]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/489?rss=1</link>
<description><![CDATA[ 
<P>To migrate, a cell first extends protrusions such as lamellipodia and filopodia, forms adhesions, and finally retracts its tail. The actin cytoskeleton plays a major role in this process. The first part of this review (sect. <SCP>ii</SCP>) describes the formation of the lamellipodial and filopodial actin networks. In lamellipodia, the WASP-Arp2/3 pathways generate a branched filament array. This polarized dendritic actin array is maintained in rapid treadmilling by the concerted action of ADF, profilin, and capping proteins. In filopodia, formins catalyze the processive assembly of nonbranched actin filaments. Cell matrix adhesions mechanically couple actin filaments to the substrate to convert the treadmilling into protrusion and the actomyosin contraction into traction of the cell body and retraction of the tail. The second part of this review (sect. <SCP>iii</SCP>) focuses on the function and the regulation of major proteins (vinculin, talin, tensin, and -actinin) that control the nucleation, the binding, and the barbed-end growth of actin filaments in adhesions.</P>
]]></description>
<dc:creator><![CDATA[Le Clainche, C., Carlier, M.-F.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00021.2007</dc:identifier>
<dc:title><![CDATA[Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell Migration]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>513</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>489</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/515?rss=1">
<title><![CDATA[Local Gene Expression in Axons and Nerve Endings: The Glia-Neuron Unit]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/515?rss=1</link>
<description><![CDATA[ 
<P>Neurons have complex and often extensively elongated processes. This unique cell morphology raises the problem of how remote neuronal territories are replenished with proteins. For a long time, axonal and presynaptic proteins were thought to be exclusively synthesized in the cell body, which delivered them to peripheral sites by axoplasmic transport. Despite this early belief, protein has been shown to be synthesized in axons and nerve terminals, substantially alleviating the trophic burden of the perikaryon. This observation raised the question of the cellular origin of the peripheral RNAs involved in protein synthesis. The synthesis of these RNAs was initially attributed to the neuron soma almost by default. However, experimental data and theoretical considerations support the alternative view that axonal and presynaptic RNAs are also transcribed in the flanking glial cells and transferred to the axon domain of mature neurons. Altogether, these data suggest that axons and nerve terminals are served by a distinct gene expression system largely independent of the neuron cell body. Such a local system would allow the neuron periphery to respond promptly to environmental stimuli. This view has the theoretical merit of extending to axons and nerve terminals the marginalized concept of a glial supply of RNA (and protein) to the neuron cell body. Most long-term plastic changes requiring de novo gene expression occur in these domains, notably in presynaptic endings, despite their intrinsic lack of transcriptional capacity. This review enlightens novel perspectives on the biology and pathobiology of the neuron by critically reviewing these issues.</P>
]]></description>
<dc:creator><![CDATA[Giuditta, A., Tai Chun, J., Eyman, M., Cefaliello, C., Bruno, A. P., Crispino, M.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00051.2006</dc:identifier>
<dc:title><![CDATA[Local Gene Expression in Axons and Nerve Endings: The Glia-Neuron Unit]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>555</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>515</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/557?rss=1">
<title><![CDATA[Telomeres and Aging]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/557?rss=1</link>
<description><![CDATA[ 
<P>Telomeres play a central role in cell fate and aging by adjusting the cellular response to stress and growth stimulation on the basis of previous cell divisions and DNA damage. At least a few hundred nucleotides of telomere repeats must "cap" each chromosome end to avoid activation of DNA repair pathways. Repair of critically short or "uncapped" telomeres by telomerase or recombination is limited in most somatic cells and apoptosis or cellular senescence is triggered when too many "uncapped" telomeres accumulate. The chance of the latter increases as the average telomere length decreases. The average telomere length is set and maintained in cells of the germline which typically express high levels of telomerase. In somatic cells, telomere length is very heterogeneous but typically declines with age, posing a barrier to tumor growth but also contributing to loss of cells with age. Loss of (stem) cells via telomere attrition provides strong selection for abnormal and malignant cells, a process facilitated by the genome instability and aneuploidy triggered by dysfunctional telomeres. The crucial role of telomeres in cell turnover and aging is highlighted by patients with 50% of normal telomerase levels resulting from a mutation in one of the telomerase genes. Short telomeres in such patients are implicated in a variety of disorders including dyskeratosis congenita, aplastic anemia, pulmonary fibrosis, and cancer. Here the role of telomeres and telomerase in human aging and aging-associated diseases is reviewed.</P>
]]></description>
<dc:creator><![CDATA[Aubert, G., Lansdorp, P. M.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00026.2007</dc:identifier>
<dc:title><![CDATA[Telomeres and Aging]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>579</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>557</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/581?rss=1">
<title><![CDATA[Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/581?rss=1</link>
<description><![CDATA[ 
<P>Mitochondria play an important role in cell death and cardioprotection. During ischemia, when ATP is progressively depleted, ion pumps cannot function resulting in a rise in calcium (Ca<SUP>2+</SUP>), which further accelerates ATP depletion. The rise in Ca<SUP>2+</SUP> during ischemia and reperfusion leads to mitochondrial Ca<SUP>2+</SUP> accumulation, particularly during reperfusion when oxygen is reintroduced. Reintroduction of oxygen allows generation of ATP; however, damage to the electron transport chain results in increased mitochondrial generation of reactive oxygen species (ROS). Mitochondrial Ca<SUP>2+</SUP> overload and increased ROS can result in opening of the mitochondrial permeability transition pore, which further compromises cellular energetics. The resultant low ATP and altered ion homeostasis result in rupture of the plasma membrane and cell death. Mitochondria have long been proposed as central players in cell death, since the mitochondria are central to synthesis of both ATP and ROS and since mitochondrial and cytosolic Ca<SUP>2+</SUP> overload are key components of cell death. Many cardioprotective mechanisms converge on the mitochondria to reduce cell death. Reducing Ca<SUP>2+</SUP> overload and reducing ROS have both been reported to reduce ischemic injury. Preconditioning activates a number of signaling pathways that reduce Ca<SUP>2+</SUP> overload and reduce activation of the mitochondrial permeability transition pore. The mitochondrial targets of cardioprotective signals are discussed in detail.</P>
]]></description>
<dc:creator><![CDATA[Murphy, E., Steenbergen, C.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00024.2007</dc:identifier>
<dc:title><![CDATA[Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>609</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>581</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/611?rss=1">
<title><![CDATA[Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/611?rss=1</link>
<description><![CDATA[ 
<P>Mitochondria contain their own genetic system and undergo a unique mode of cytoplasmic inheritance. Each organelle has multiple copies of a covalently closed circular DNA genome (mtDNA). The entire protein coding capacity of mtDNA is devoted to the synthesis of 13 essential subunits of the inner membrane complexes of the respiratory apparatus. Thus the majority of respiratory proteins and all of the other gene products necessary for the myriad mitochondrial functions are derived from nuclear genes. Transcription of mtDNA requires a small number of nucleus-encoded proteins including a single RNA polymerase (POLRMT), auxiliary factors necessary for promoter recognition (TFB1M, TFB2M) and activation (Tfam), and a termination factor (mTERF). This relatively simple system can account for the bidirectional transcription of mtDNA from divergent promoters and key termination events controlling the rRNA/mRNA ratio. Nucleomitochondrial interactions depend on the interplay between transcription factors (NRF-1, NRF-2, PPAR, ERR, Sp1, and others) and members of the PGC-1 family of regulated coactivators (PGC-1, PGC-1&beta;, and PRC). The transcription factors target genes that specify the respiratory chain, the mitochondrial transcription, translation and replication machinery, and protein import and assembly apparatus among others. These factors are in turn activated directly or indirectly by PGC-1 family coactivators whose differential expression is controlled by an array of environmental signals including temperature, energy deprivation, and availability of nutrients and growth factors. These transcriptional paradigms provide a basic framework for understanding the integration of mitochondrial biogenesis and function with signaling events that dictate cell- and tissue-specific energetic properties.</P>
]]></description>
<dc:creator><![CDATA[Scarpulla, R. C.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00025.2007</dc:identifier>
<dc:title><![CDATA[Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>638</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>611</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/639?rss=1">
<title><![CDATA[Molecular Physiology of Bestrophins: Multifunctional Membrane Proteins Linked to Best Disease and Other Retinopathies]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/639?rss=1</link>
<description><![CDATA[ 
<P>This article reviews the current state of knowledge about the bestrophins, a newly identified family of proteins that can function both as Cl<SUP>&ndash;</SUP> channels and as regulators of voltage-gated Ca<SUP>2+</SUP> channels. The founding member, human bestrophin-1 (hBest1), was identified as the gene responsible for a dominantly inherited, juvenile-onset form of macular degeneration called Best vitelliform macular dystrophy. Mutations in hBest1 have also been associated with a small fraction of adult-onset macular dystrophies. It is proposed that dysfunction of bestrophin results in abnormal fluid and ion transport by the retinal pigment epithelium, resulting in a weakened interface between the retinal pigment epithelium and photoreceptors. There is compelling evidence that bestrophins are Cl<SUP>&ndash;</SUP> channels, but bestrophins remain enigmatic because it is not clear that the Cl<SUP>&ndash;</SUP> channel function can explain Best disease. In addition to functioning as a Cl<SUP>&ndash;</SUP> channel, hBest1 also is able to regulate voltage-gated Ca<SUP>2+</SUP> channels. Some bestrophins are activated by increases in intracellular Ca<SUP>2+</SUP> concentration, but whether bestrophins are the molecular counterpart of Ca<SUP>2+</SUP>-activated Cl<SUP>&ndash;</SUP> channels remains in doubt. Bestrophins are also regulated by cell volume and may be a member of the volume-regulated anion channel family.</P>
]]></description>
<dc:creator><![CDATA[Hartzell, H. C., Qu, Z., Yu, K., Xiao, Q., Chien, L.-T.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00022.2007</dc:identifier>
<dc:title><![CDATA[Molecular Physiology of Bestrophins: Multifunctional Membrane Proteins Linked to Best Disease and Other Retinopathies]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>672</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>639</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/673?rss=1">
<title><![CDATA[Physiology of the Prion Protein]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/673?rss=1</link>
<description><![CDATA[ 
<P>Prion diseases are transmissible spongiform encephalopathies (TSEs), attributed to conformational conversion of the cellular prion protein (PrP<SUP>C</SUP>) into an abnormal conformer that accumulates in the brain. Understanding the pathogenesis of TSEs requires the identification of functional properties of PrP<SUP>C</SUP>. Here we examine the physiological functions of PrP<SUP>C</SUP> at the systemic, cellular, and molecular level. Current data show that both the expression and the engagement of PrP<SUP>C</SUP> with a variety of ligands modulate the following: <I>1</I>) functions of the nervous and immune systems, including memory and inflammatory reactions; <I>2</I>) cell proliferation, differentiation, and sensitivity to programmed cell death both in the nervous and immune systems, as well as in various cell lines; <I>3</I>) the activity of numerous signal transduction pathways, including cAMP/protein kinase A, mitogen-activated protein kinase, phosphatidylinositol 3-kinase/Akt pathways, as well as soluble non-receptor tyrosine kinases; and <I>4</I>) trafficking of PrP<SUP>C</SUP> both laterally among distinct plasma membrane domains, and along endocytic pathways, on top of continuous, rapid recycling. A unified view of these functional properties indicates that the prion protein is a dynamic cell surface platform for the assembly of signaling modules, based on which selective interactions with many ligands and transmembrane signaling pathways translate into wide-range consequences upon both physiology and behavior.</P>
]]></description>
<dc:creator><![CDATA[Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., Brentani, R. R.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00007.2007</dc:identifier>
<dc:title><![CDATA[Physiology of the Prion Protein]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>728</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>673</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/729?rss=1">
<title><![CDATA[Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/729?rss=1</link>
<description><![CDATA[ 
<P>The importance of &beta;-adrenergic signaling in the heart has been well documented, but it is only more recently that we have begun to understand the importance of this signaling pathway in skeletal muscle. There is considerable evidence regarding the stimulation of the &beta;-adrenergic system with &beta;-adrenoceptor agonists (&beta;-agonists). Although traditionally used for treating bronchospasm, it became apparent that some &beta;-agonists could increase skeletal muscle mass and decrease body fat. These so-called "repartitioning effects" proved desirable for the livestock industry trying to improve feed efficiency and meat quality. Studying &beta;-agonist effects on skeletal muscle has identified potential therapeutic applications for muscle wasting conditions such as sarcopenia, cancer cachexia, denervation, and neuromuscular diseases, aiming to attenuate (or potentially reverse) the muscle wasting and associated muscle weakness, and to enhance muscle growth and repair after injury. Some undesirable cardiovascular side effects of &beta;-agonists have so far limited their therapeutic potential. This review describes the physiological significance of &beta;-adrenergic signaling in skeletal muscle and examines the effects of &beta;-agonists on skeletal muscle structure and function. In addition, we examine the proposed beneficial effects of &beta;-agonist administration on skeletal muscle along with some of the less desirable cardiovascular effects. Understanding &beta;-adrenergic signaling in skeletal muscle is important for identifying new therapeutic targets and identifying novel approaches to attenuate the muscle wasting concomitant with many diseases.</P>
]]></description>
<dc:creator><![CDATA[Lynch, G. S., Ryall, J. G.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00028.2007</dc:identifier>
<dc:title><![CDATA[Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>767</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>729</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://physrev.physiology.org/cgi/content/abstract/88/2/769?rss=1">
<title><![CDATA[Dendritic Excitability and Synaptic Plasticity]]></title>
<link>http://physrev.physiology.org/cgi/content/abstract/88/2/769?rss=1</link>
<description><![CDATA[ 
<P>Most synaptic inputs are made onto the dendritic tree. Recent work has shown that dendrites play an active role in transforming synaptic input into neuronal output and in defining the relationships between active synapses. In this review, we discuss how these dendritic properties influence the rules governing the induction of synaptic plasticity. We argue that the location of synapses in the dendritic tree, and the type of dendritic excitability associated with each synapse, play decisive roles in determining the plastic properties of that synapse. Furthermore, since the electrical properties of the dendritic tree are not static, but can be altered by neuromodulators and by synaptic activity itself, we discuss how learning rules may be dynamically shaped by tuning dendritic function. We conclude by describing how this reciprocal relationship between plasticity of dendritic excitability and synaptic plasticity has changed our view of information processing and memory storage in neuronal networks.</P>
]]></description>
<dc:creator><![CDATA[Sjostrom, P. J., Rancz, E. A., Roth, A., Hausser, M.]]></dc:creator>
<dc:date>2008-04-07</dc:date>
<dc:identifier>info:doi/10.1152/physrev.00016.2007</dc:identifier>
<dc:title><![CDATA[Dendritic Excitability and Synaptic Plasticity]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>88</prism:volume>
<prism:endingPage>840</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>769</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

</rdf:RDF>